Lexaria Bioscience - Warrants (11/01/2026) Insider Trades

LEXXW

Track insider trading activity from Lexaria Bioscience - Warrants (11/01/2026) executives and directors. See which insiders are buying and selling LEXXW stock.

Trades Last 12 Months

LEXXW Price

All Insider Trades for Lexaria Bioscience - Warrants (11/01/2026)

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $328 273,543 shares
Last Trade
Mar 17, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$120 100,000 shares
$0.00
$0.00
Holding Value $21.8 18,191 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$600 5,000 shares
$0.12
$0.00
Carle Vanessa Secretary
Holding Value $0.9 750 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90 750 shares
$0.12
$0.00
Christopher Richard Chief Executive Officer
Holding Value $78 65,000 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.8k 15,000 shares
$0.12
$0.00
Docherty John Martin President & CSO
Holding Value $6.45 5,376 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$645 5,376 shares
$0.12
$0.00
Holding Value $51.6 43,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9k 11,000 shares
$0.17
$0.00
Holding Value $13.2 11,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9k 11,000 shares
$0.17
$0.00
Holding Value $75.6 63,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9k 11,000 shares
$0.17
$0.00
Shankman Michael Elliot Chief Financial Officer
Holding Value $120 100,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.64k 50,000 shares
$0.17
$0.00
Holding Value $3.72 3,100 shares
Last Trade
Aug 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.08k 1,600 shares
$1.30
$0.00
Cabatuan Nelson Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 15, 2024 Sale
$206k 200,000 shares
$1.03
$0.00
Downey Gregory Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Apr 15, 2023 Sale
$2.6k 4,000 shares
$0.65
$0.00
Holding Value $14.2 11,800 shares
Last Trade
Mar 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57k 3,400 shares
$1.05
$0.00
Quigley Brian W. Director
Holding Value $120 100,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Spissinger Allan Horst Chief Financial Officer
Holding Value $780 650,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Demartini David Director
Holding Value $120 100,000 shares
Last Trade
Jun 18, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Holding Value $0 0 shares
Last Trade
Jul 08, 2011 Sale
No data
No data
$0.00
Ihrke Thomas James Sr. Vp, Business Developement
Holding Value $300 250,385 shares
Last Trade
Dec 22, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up